These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 7540236)

  • 1. Cytokeratin patterns of liver carcinomas induced by diethylnitrosamine in monkeys.
    Lapis K; Sarosi I; Bocsi J; Thorgeirsson UP
    Lab Invest; 1995 Jun; 72(6):748-59. PubMed ID: 7540236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnostic value of cytokeratins and carcinoembryonic antigen immunostaining in differentiating hepatocellular carcinomas from intrahepatic cholangiocarcinomas.
    Stroescu C; Herlea V; Dragnea A; Popescu I
    J Gastrointestin Liver Dis; 2006 Mar; 15(1):9-14. PubMed ID: 16680226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric DNA-ploidy and proliferative activity of diethylnitrosamine-induced hepatocellular carcinoma and pulmonary metastases in monkeys.
    Lapis K; Bocsi J; Lapis P; Thorgeirsson UP
    Hepatology; 1995 Sep; 22(3):952-61. PubMed ID: 7657303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical profiles of Mallory body by a panel of anti-cytokeratin antibodies.
    Pei RJ; Danbara N; Tsujita-Kyutoku M; Yuri T; Tsubura A
    Med Electron Microsc; 2004 Jun; 37(2):114-8. PubMed ID: 15221653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the proliferative activity of diethylnitrosamine-induced hepatocellular carcinomas in monkeys.
    Lapis K; Bocsi J; Timar F; Lapis P; Thorgeirsson UP
    J Pathol; 1997 Apr; 181(4):439-43. PubMed ID: 9196443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression of cytokeratins 7, 19, and 20 in primary and metastatic carcinomas of the liver.
    Maeda T; Kajiyama K; Adachi E; Takenaka K; Sugimachi K; Tsuneyoshi M
    Mod Pathol; 1996 Sep; 9(9):901-9. PubMed ID: 8878022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization of antihepatocyte clone OCH1E5 (Hep Par 1) in histological evaluation of liver tumors.
    Amarapurkar AD; Rege JD; Joshi AS; Vaiphei K; Amarapurkar DN
    Indian J Pathol Microbiol; 2006 Jul; 49(3):341-4. PubMed ID: 17001880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic relationship between oval cells and a subpopulation of hepatic foci, nodules, and carcinomas induced by the "resistant hepatocyte" model system.
    Faris RA; Monfils BA; Dunsford HA; Hixson DC
    Cancer Res; 1991 Feb; 51(4):1308-17. PubMed ID: 1997169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different lineages of chemically induced hepatocellular carcinoma in rats defined by monoclonal antibodies.
    Dunsford HA; Karnasuta C; Hunt JM; Sell S
    Cancer Res; 1989 Sep; 49(17):4894-900. PubMed ID: 2474377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneously occurring hepatocellular neoplasia in adolescent cynomolgus monkeys (Macaca fascicularis).
    Reindel JF; Walsh KM; Toy KA; Bobrowski WF
    Vet Pathol; 2000 Nov; 37(6):656-62. PubMed ID: 11105957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic significance of aquaporin-1 in liver tumors.
    Mazal PR; Susani M; Wrba F; Haitel A
    Hum Pathol; 2005 Nov; 36(11):1226-31. PubMed ID: 16260277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Keratin polypeptides in malignant epithelial liver tumors. Differential diagnostic and histogenetic aspects.
    Fischer HP; Altmannsberger M; Weber K; Osborn M
    Am J Pathol; 1987 Jun; 127(3):530-7. PubMed ID: 2438941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Sialyl Lewis X expression in hepatocarcinogenesis: potential predictor for the emergence of hepatocellular carcinoma.
    Fujiwara Y; Shimada M; Takenaka K; Kajiyama K; Shirabe K; Sugimachi K
    Hepatogastroenterology; 2002; 49(43):213-7. PubMed ID: 11941958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of cytokeratin 19-positive biliary cells in cirrhotic nodules, hepatic borderline nodules (atypical adenomatous hyperplasia), and small hepatocellular carcinomas.
    Terada T; Hoso M; Nakanuma Y
    Mod Pathol; 1995 May; 8(4):371-9. PubMed ID: 7567933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma.
    Lau SK; Prakash S; Geller SA; Alsabeh R
    Hum Pathol; 2002 Dec; 33(12):1175-81. PubMed ID: 12514785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
    Tátrai P
    Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HCC CKs are altered histones during tumor transformation in hepatoma.
    Liu YH; Pei RJ; Cheng CC; Ho HC; Ho CC; Yeh KT; Lee KY; Lai YS
    Res Commun Mol Pathol Pharmacol; 2002; 112(1-4):27-38. PubMed ID: 15080494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-erb-B-2 oncoprotein and epidermal growth factor receptor in human hepatocellular carcinoma: an immunohistochemical study.
    Nakopoulou L; Stefanaki K; Filaktopoulos D; Giannopoulou I
    Histol Histopathol; 1994 Oct; 9(4):677-82. PubMed ID: 7894139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative immunohistochemical expression of p63 in human cholangiocarcinoma and hepatocellular carcinoma.
    Ramalho FS; Ramalho LN; Della Porta L; Zucoloto S
    J Gastroenterol Hepatol; 2006 Aug; 21(8):1276-80. PubMed ID: 16872309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.